Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Carbohydrate doai
Reexamination Certificate
2002-06-03
2004-01-13
Barts, Samuel (Department: 1623)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Carbohydrate doai
C536S123100, C536S124000, C536S119000, C536S115000
Reexamination Certificate
active
06677318
ABSTRACT:
This is the National Phase Application of PCT EP00/08646 filed Sep. 5, 2000.
The present invention relates to a composition for producing a satiation effect.
Numerous attempts have been made by medical means to break down excessive accumulations of fat in the human body, or to prevent them developing. There are, for example, appetite suppressants which attempt by biochemical means to induce in the body a disinclination to take food. These compositions have in some cases considerable harmful side effects.
Besides the numerous dietary products which have been proposed, there are also mechanical and electromechanical means intended specifically to break down fat and build up muscle. However, the effect of such means is very doubtful.
German Patent DE 402,5912 discloses a composition for oral intake which consists of a container which is soluble in the stomach and releases the contents. This container is filled with a substance whose volume increases after it is released in the stomach, and thus it induces a feeling of satiation in the body.
From the prior art a number of elastic materials are already known that can be compressed on passage through the esophagus and which can, after leaving the esophagus, be decompressed in water and/or gastrointestinal fluid. Such sponge-like structures are taken to mean foams which consist of gas-filled spherical/polyhedral cells which are limited by highly viscous or solid cell walls. It is possible to employ according to the invention both naturally occurring sponges and synthetically prepared sponge-like structures.
Natural materials which are already used are collagen and cellulose. However, these abovementioned materials are relatively expensive raw materials. Both materials require complex isolation or work-up processes which, in addition, are very environmentally polluting. The latter applies especially to cellulose, the isolation of which means that large amounts of acids have to be employed.
Soluble collagen is isolated from animal hides, for example, preferably young cattle or pigs, since the soluble collagen content in the animal becomes ever smaller with increasing age. This is also only possible with complex isolation and work-up processes.
Not least since the discovery of a number of diseases in pigs and cattle, which are suspected to be transmissible to humans, in particular the cattle disease BSE, and a possible risk of infection for humans, the acceptance of such collagen-containing products by the end consumer has fallen drastically.
It is an object of the present invention, therefore, to provide a material for preparing a composition for producing a long-lasting satiation effect, which material does not have the abovementioned disadvantages.
This is achieved according to the invention by a composition for oral intake comprising uronic-acid-containing polysaccharides stably crosslinked to one another in the form of a sponge-like structure which is characterized in that it is slightly soluble or of low absorbability in water and/or gastrointestinal fluids.
According to the invention the uronic-acid-containing polysaccharides are crosslinked to one another by ionic bonds and in addition are stably crosslinked to one another by covalent bonds. Particularly preferred polyuronic acid-containing-polysaccharides are alginic acids and their salts (alginates). However, low degree of esterification pectins, xanthan, tragacanth, chondroitin sulfate and all other uronic-acid-containing compounds can also be used according to the invention.
Alginic acid is a linear polyuronic acid of alternating parts of D-mannuronic acid and L-guluronic acid which are linked to one another by &bgr;-glycosidic bonds, the carboxyl groups not being esterified. One molecule of alginic acid can be composed of about 150-1 050 uronic acid units, where the mean molecular weight can range from 30-200 kDa.
The polysaccharide alginic acid is a constituent of cell walls of brown algae. The alginic acid content can make up to 40% of the dry matter of the algae in this case. The alginic acid is produced by alkaline extraction with methods known per se according to the prior art. The resultant pulverulent alginic acid is thus purely of plant origin and has high biocompatibility. It can absorb 300 times its own weight of water, forming highly viscous solutions. In the presence of polyvalent cations, alginic acid forms gels. The formation of alginate gels in the presence of divalent cations, such as calcium or barium, is described in Shapiro I., et al. (Biomaterials, 1997, 18: 583-90). The latter is not suitable for use in biomedicine, however, on account of its toxicity. In addition to calcium chloride, calcium gluconate also provides suitable divalent cations. In general, all physiologically safe polycations can be used, in particular divalent cations. The unbranched concertina-like alginate chains are fixed by ionic bonds via the free bonding positions of the cations, preferably calcium ions (FIG.
1
). This produces a three-dimensional network in which the divalent cations are situated like “eggs in an eggbox” as in the “egg-box model” presented in Smidsrod et al. (Trends in Biotechnology, 1990, 8: 71).
The sponge-like or sponge-shaped structures are produced by methods known per se from the prior art. Depending on the starting material employed, in the simplest case, a foam can be obtained by blowing, by beating, shaking, spraying or stirring in the relevant gas atmosphere. In the case of polymers, the foam structure is produced by chemical reactions. Thus, for example, polyurethanes are foamed by adding blowing agents which decompose at a defined temperature during processing, with gas formation, or by addition of liquid solvents during the polymerization. The foaming takes place either on leaving the extrusion die, that is to say following the extrusion or injection molding, or in open molds. The curing takes place under the conditions characteristic of the respective chemical compound of the material.
An indispensable prerequisite for the usability of the material is that it can be compressed without breaking the cell walls. This is because in order to be able to use the inventive material for oral intake, the foam-like or foamy material must be directly compressible on passage through the esophagus. In particular, no trouble must occur on passage through the esophagus.
A particular advantage of the present invention is that the alginates crosslinked according to the invention are more flexible and softer, and as a result have very much more favorable mechanical properties for gastrointestinal application than the materials previously available on the market. For the user this is accompanied by the advantage of improved tolerance, so that even in the case of patients having mucosal lesions, neither a feeling of pressure nor mucosal irritation is caused.
For the selection of the material and the type of foam formation, it is furthermore essential that the material remains swellable without destroying the cell walls. After passage through the esophagus, the sponge-like structure is to resume at least the size which it had before entry into the esophagus. If appropriate, the material may also swell to a size which goes beyond the original volume.
The sponge-like structure can have any desired shape and size in the compressed and decompressed states. However, preference is given to cuboid or rectangular or round embodiments.
Preferably, the material is designed so that the sponge-like structure can be compressed to ½ to {fraction (1/100)}, preferably ¼ to {fraction (1/50)}, particularly preferably {fraction (1/10)} to {fraction (1/20)}, of its volume or of its size. Under physiological conditions, the compressed material, after passage through the esophagus, is to be able to expand, preferably to two to twenty times, particularly preferably to four to fifty times, and very particularly preferably to ten to twenty times, its volume.
As material for the sponge-like structure, according to the invention natural, semisynthetic or synthetic polymers can be us
Barts Samuel
Henry Michael C
Kueffner Friedrich
LandOfFree
Cross-linked agent for generation of a long-lasting satiety... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Cross-linked agent for generation of a long-lasting satiety..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Cross-linked agent for generation of a long-lasting satiety... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3209133